SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Therapeutic mechanisms of psychedelics and entactogens
16 references·0 citing·24 second hop
Therapeutic mechanisms of psychedelics and entactogens (2023)Therapeutic mechanisms of psychedelics an…Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Single-Dose Psilocybin for a …Trial of Psilocybin versus Escitalopram for Depression (2021)Trial of Psilocybin versus Es…MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (2021)MDMA-assisted therapy for sev…Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Effects of Psilocybin-Assiste…REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)REBUS and the Anarchic Brain:…Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (2018)Rapid antidepressant effects …Psychedelics Promote Structural and Functional Neural Plasticity (2018)Psychedelics Promote Structur…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Pilot study of the 5-HT 2A R …Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin (2013)Social reward requires coordi…Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders (2010)Research Domain Criteria (RDo…Human hallucinogen research: guidelines for safety (2008)Human hallucinogen research: …Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Hallucinogens Recruit Specifi…Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)DSM‐IV‐TR: Diagnostic and Statistical Manual of Mental Disorders (2013)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Manual for the State-Trait Anxiety Inventory (1970)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)A RATING SCALE FOR DEPRESSION (1960)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)A New Depression Scale Designed to be Sensitive to Change (1979)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial (2022)Psilocybin desynchronizes the human brain (2024)Toward the future of psychiatric diagnosis: the seven pillars of RDoC (2013)Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective (2013)The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry (2014)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)Increased global integration in the brain after psilocybin therapy for depression (2022)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)
this work references cited by second hop

References

  • 2010Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders7,058 cited
  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2021Trial of Psilocybin versus Escitalopram for Depression1,386 cited
  • 2020Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder1,296 cited
  • 2008Human hallucinogen research: guidelines for safety1,201 cited
  • 2018Psychedelics Promote Structural and Functional Neural Plasticity1,201 cited
  • 2019REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics1,175 cited
  • 2022Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression1,164 cited
  • 2013Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin1,161 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 2021MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study996 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2007Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior922 cited
  • 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
  • 2018Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial851 cited
  • Cited by

    No citing works inside the corpus for this window.